investordatabase.org

1921.vc (Nineteen Twenty-One)

1921.vc Direct investor

Nineteen Twenty-One is a Vienna-based venture capital fund focused on type 1 diabetes and related conditions. It makes early-stage investments, typically as first money in up to select Series A rounds, and works with a network of clinicians, researchers and industry professionals.

1921.vc (Nineteen Twenty-One) is a venture capital firm headquartered in Vienna, Austria, founded in 2024. It invests directly in companies, from pre-seed to Series A, in type 1 diabetes, diabetes care, e-health and digital therapeutics. Its stated cheque size is €200k-1.5M, depending on stage. 8 portfolio companies, as it reports.

“We back mission-driven teams building tech-enabled or biology-driven solutions, fast and without excuses.”

— 1921.vc (Nineteen Twenty-One), own website
Layer
Direct investor
Type
Venture capital
Stage
Pre-seed – Series A
Headquarters
Vienna, Austria
Invests in
EU, global
Sectors
type 1 diabetes, diabetes care, e-health, digital therapeutics, AI/ML, devices, services, research
Cheque size
€200k-1.5M, depending on stage
Founded
2024
Portfolio
8 companies

Team, as 1921.vc (Nineteen Twenty-One) publishes it

  • Fredrik Debong Founder, leads the fund

Names and roles exactly as listed on 1921.vc. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page 1921.vc (Nineteen Twenty-One) publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://1921.vc/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, cheque_size, thesis_quote, description, founded, portfolio_count, people, status
Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 21877 · added 2026-11-16 · link last verified 2026-11-16 · confidence high

Similar investors

Listed under